FAP and malignant glioma: To compare the HEK cell-based model we investigated in Figure 3 with more clinically relevant specimens, we compared FAPVap cleavage by the FAP-expressing cells used in our in vivo experiments with cleavage by the established U138 malignant glioma cell line, which naturally expresses FAP at substantial levels (Busek et al., 2008).